VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma. Results of a prospective randomised trial.

被引：0
|
作者：
Santini, G [1 ]
Salvagno, L [1 ]
Leoni, P [1 ]
Chisesi, T [1 ]
Rizzoli, V [1 ]
机构：
[1] S Martino Hosp, Dept Haematol, Genova, Italy
来源：
EXPERIMENTAL HEMATOLOGY | 1998年 / 26卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
234
引用
收藏
页码：746 / 746
页数：1
相关论文
共 50 条
  • [1] VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma. Results of a prospective randomised trial
    Santini, G
    Salvagno, L
    Leoni, P
    Chisesi, T
    Rizzoli, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 152 - 152
  • [2] VACOP-B vs VACOP-B+ABMT for aggressive non-Hodgkin's lymphoma (NHL). Results of a prospective randomised trial.
    Santini, G
    Salvagno, L
    Leoni, P
    Chisesi, T
    Congiu, AM
    Rizzoli, V
    BLOOD, 1998, 92 (10) : 465A - 465A
  • [3] VACOP-B versus VACOP-B plus High-Dose Sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma. Interim analysis of a randomised trial.
    Santini, G
    Leoni, P
    Majolino, I
    BONE MARROW TRANSPLANTATION, 2001, 27 : S13 - S13
  • [4] Vacop-B vs Vacop-B plus high-dose sequential therapy (HDS) for aggressive non-Hodgkin's lymphoma (NHL)
    Santini, G
    Congiu, A
    Olivieri, A
    Malolino, I
    Chisesi, T
    Salvagno, L
    Quaini, R
    Rubagotti, A
    Centurioni, R
    Contu, A
    Candela, M
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 2002, 29 : S8 - S9
  • [5] VACOP-B vs VACOP-B plus high-dose sequential therapy (RDS) for aggressive non-Hodgkin's lymphoma (NHL).
    Santini, G
    Olivieri, A
    Majolino, I
    Chisesi, T
    Salvagno, L
    Biglio, A
    de Souza, C
    Congiu, M
    Rizzoli, V
    BLOOD, 2001, 98 (11) : 862A - 862A
  • [6] VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: Results of a prospective randomized trial by the non-Hodgkin's lymphoma cooperative study group
    Santini, G
    Salvagno, L
    Leoni, P
    Chisesi, T
    De Souza, C
    Sertoli, MR
    Rubagotti, A
    Congiu, AM
    Centurioni, R
    Olivieri, A
    Tedeschi, L
    Vespignani, M
    Nati, S
    Soracco, M
    Porcellini, A
    Contu, A
    Guarnaccia, C
    Pescosta, N
    Majolino, I
    Spriano, M
    Vimercati, R
    Rossi, E
    Zambaldi, G
    Mangoni, L
    Endrizzi, L
    Sileni, VC
    Miggiano, MC
    Marino, G
    Damasio, E
    Rizzoli, V
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2796 - 2802
  • [7] Vacop-B versus Vacop-B plus high-dose sequential therapy for aggressive non-Hodgkin's lymphoma - final analysis of the NHLCSG
    Santini, G
    Olivieri, A
    Majolino, I
    Congiu, A
    Chisesi, T
    De Souza, C
    Patti, C
    Salvagno, L
    Quaini, R
    Rubagotti, A
    Centurioni, R
    Contu, A
    Candela, M
    Rizzoli, V
    BONE MARROW TRANSPLANTATION, 2003, 31 : S5 - S5
  • [8] VACOP-B for stage I/II aggressive non-Hodgkin's lymphoma: Report from the NHLCSG.
    Santini, G
    Salvagno, L
    Majolino, I
    Chisesi, T
    Candela, M
    Olivieri, A
    Tedeschi, L
    Vivaldi, P
    Contu, T
    Coser, P
    Rizzoli, V
    Rubagotti, A
    Endrizzi, L
    Porcellini, A
    De Souza, C
    BLOOD, 2000, 96 (11) : 247B - 247B
  • [9] The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma
    Dreiher, J
    Shpilberg, O
    Raamami, P
    Chetrit, A
    Ben-Bassat, I
    LEUKEMIA RESEARCH, 1998, 22 (11) : 997 - 1002
  • [10] Prospective randomised study comparing 12-week VACOP-B regimen versus 6-week VACOP-B plus high-dose sequential followed by autologous bone marrow transplantation in high-risk IPI aggressive non-Hodgkin lymphoma. A Brazilian GEMOH report
    De Souza, CA
    Cardoso, RB
    Simoes, BP
    Maiolino, A
    Moraes, AJG
    Ruiz, MA
    Lorand-Metze, IGH
    Vigorito, AC
    Aranha, FJP
    Miranda, ECM
    Nucci, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S349 - S349
12345